• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: THERAKOS CELLEX PHOTOPHERESIS SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

THERAKOS CELLEX PHOTOPHERESIS SYSTEM Back to Search Results
Model Number NOT APPLICABLE
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Pulmonary Embolism (1498); Dyspnea (1816); Respiratory Failure (2484)
Event Date 04/18/2018
Event Type  Injury  
Manufacturer Narrative
The system was used for treatment.This case is reportable as a mdr due to the medical intervention of the bilevel positive airway pressure heparin, and lovenox that were provided to the patient.Since this event is associated with the treatment, this mdr will be against the instrument.From the instrument perspective, there was no known instrument malfunction and no instrument issue was alleged by the customer.No service was requested by the customer for this adverse event.An instrument serial number was not provided within the user facility report thus a device service history review could not be conducted for this case.Trends were reviewed for complaint categories, shortness of breath, respiratory failure, and pulmonary embolism.No trends were detected for these complaint categories.The assessment is based on information available at the time of the investigation.Complaints are monitored through tracking and trending.If a trend is detected, further investigation will be conducted.Adverse event terms: dyspnea, respiratory failure, and pulmonary embolism.(b)(4).
 
Event Description
The below user facility report, mw5077642, was discovered in the fda's maude database during an annual review.As we were unable to reconcile this report, it was added to our complaint database and determined to be reportable.As the reporter was not identified within user facility report, a follow-up could not be performed regarding this report.The patient had been receiving one to two extracorporeal photopheresis (ecp) treatment procedures for the treatment of chronic graft versus host disease (cgvhd) since 2016.The patient's cgvhd symptoms resulted primarily in significant sclerodermatous changes that affected the patient's extremities and trunk.These sclerodermatous changes caused the patient to experience dyspnea.The patient was seen for her routine outpatient ecp treatment procedure on an unknown date in 2018.Prior to her ecp treatment procedure, the patient reported that she had been diagnosed a week earlier with an upper respiratory infection.The patient stated that she was currently being treated with a course of azithromycin and advair for her upper respiratory infection.Heparin had been used as the anticoagulant for the patient's ecp treatment procedure and the patient's ecp treatment procedure was uneventful.On (b)(6) 2018 the patient went to the emergency room due to worsening dyspnea.The patient was ultimately admitted to the medical intensive care unit for respiratory failure.The patient's lab results were significant for the findings of a new pulmonary embolism at the bifurcation of her left main pulmonary artery.This pulmonary embolism, along with her upper respiratory infection and underlying gvhd condition, was thought to have contributed to the patient's respiratory distress.The patient was stable on bilevel positive airway pressure and was also receiving both antibiotics and heparin.In addition, the patient was transitioning from heparin to lovenox.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CELLEX PHOTOPHERESIS SYSTEM
Type of Device
CELLEX PHOTOPHERESIS SYSTEM
Manufacturer (Section D)
THERAKOS
bedminster NJ
Manufacturer (Section G)
MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
college business & tech park
cruiserath road
blanchardstown, dublin, D15 T X2V
EI   D15 TX2V
Manufacturer Contact
megan vernak
1425 us route 206
bedminster, NJ 07921
MDR Report Key9211388
MDR Text Key175756511
Report Number2523595-2019-00125
Device Sequence Number1
Product Code LNR
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P860003
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,user f
Reporter Occupation Non-Healthcare Professional
Type of Report Initial
Report Date 10/18/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberNOT APPLICABLE
Device Catalogue NumberCELLEX
Device Lot NumberNOT APPLICABLE
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 09/18/2019
Initial Date FDA Received10/18/2019
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-